Repeated binge exposures to amphetamine and methamphetamine: Behavioral and neurochemical characterization

Journal of Pharmacology and Experimental Therapeutics

Volumn 282, Issue 2, 1997, Pages 561-573

  Segal, David S ^a,b   Kuczenski, Ronald ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHETAMINE DERIVATIVE; DOPAMINE; METHAMPHETAMINE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BEHAVIOR MODIFICATION; DOPAMINE RELEASE; DOSE TIME EFFECT RELATION; DRUG ABUSE; DRUG MEGADOSE; LOCOMOTION; MALE; NEUROCHEMISTRY; NONHUMAN; PRIORITY JOURNAL; RAT; SUBCUTANEOUS DRUG ADMINISTRATION;

AMPHETAMINE; ANIMALS; AREA UNDER CURVE; CAUDATE NUCLEUS; DOPAMINE; MALE; METHAMPHETAMINE; MOTOR ACTIVITY; PUTAMEN; RATS; RATS, SPRAGUE-DAWLEY; SEROTONIN; STEREOTYPED BEHAVIOR;

EID: 0030746306     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. ANGRIST, B.: Clinical effects of central nervous system stimulants: A selective update. In Brain Reward Systems and Abuse, ed. by J. Engel and L. Oreland, pp. 109-127, Raven Press, New York, 1987.
2. ANGRIST, B.: Psychosis-inducing effects of cocaine may show sensitization more than other effects. Neuropsychopharmacology 10: 197S, 1994a.
3. ANGRIST, B.: Amphetamine psychosis: Clinical variations of the syndrome. In Amphetamine and its analogues, ed. by A. K. Cho and D. S. Segal, pp. 387-114, Academic Press, San Diego, 1994b.
4. BENET, L. Z., MITCHELL, J. R. AND SHEINER, L. B.: Pharmacokinetics: The dynamics of drug absorption, distribution, and elimination. In Goodman and Gilman's The pharmacological basis of therapeutics, ed. by A. G. Gilman, T. W. Rall, A. S. Nies, and P. Taylor, pp. 3-32, Pergamon Press, New York, 1990.
5. BENVENISTE, H., HANSEN, A. J. AND OTTOSEN, N. S.: Determination of brain interstitial concentrations by microdialysis. J. Neurochem. 52: 1741-1740, 1989.
6. CASTAÑEDA, E., WHISHAW, I. Q. AND ROBINSON, T. E.: Changes in striatal dopamine neurotransmission assessed with microdialysis following recovery from a bilateral 6-OHDA lesion: Variation as a function of lesion size. J. Neurosci. 10: 1847-1854, 1990.
7. CHURCH, W. H., JUSTICE, J. B., JR. AND NEILL, D. B.: Detecting behaviorally relevant changes in extracellular dopamine with microdialysis. Brain Res. 412: 397-399, 1987.
8. CLAUSING, P., GOUGH, B., HOLSON, R. R., SLIKKER, W., JR. AND BOWYER, J. F.: Amphetamine levels in brain microdialysate, caudate/putamen, substantia nigra and plasma after dosage that produces either behavioral or neurotoxic effects. J. Pharmacol. Exp. Ther. 274: 614-621, 1995.
9. DAVIS, J. M. AND SCHLEMMER, JR.: The amphetamine psychosis. In Amphetamines and Related Stimulants: Chemical, Biological, Clinical and Social Aspects, ed. by J. Caldwell, pp. 161-173, CRC Press, Boca Raton, FL, 1980.
10. EICHLER, A. J., ANTELMAN, S. M. AND BLACK, C. A.: Amphetamine stereotypy is not a homogenous phenomenon: Sniffing and licking show distinct profiles of sensitization and tolerance. Psychopharmacology 68: 287-290, 1980.
11. ELLISON, G., EISON, M. S., HUBERMAN, H. S. AND DANIEL, F.: Long-term changes in dopaminergic innervation of caudate nucleus after continuous amphetamine administration. Science 276-278, 1978.
12. ELLISON, G. AND EISON, M. S.: Continuous amphetamine intoxication: An animal model of the acute psychotic episode. Psychol. Med. 13: 751-761, 1983.
13. FISCHMAN, M. W. AND SCHUSTER, C. R.: Tolerance development to chronic methamphetamine intoxication in the rhesus monkey. Pharmacol. Biochem. Behav. 2: 503-508, 1974.
14. FISCHMAN, M. W., SCHUSTER, C., JAVAID, J., HATANO, Y. AND DAVIS, J.: Acute tolerance development to the cardiovascular and subjective effects of cocaine. J. Pharmacol. Exp. Ther. 235: 677-682, 1985.
15. GAWIN, F. H.: Cocaine addiction: Psychology and neurophysiology. Science 251: 1580-1586, 1991.
16. GAWIN, F. H. AND KHALSA, M. E.: Sensitization and 'street' stimulant addiction. In Neurotoxicity and Neuropathology Associated with Stimulant Abuse. NIDA Research Monograph Series, ed. by M. D. Majewska, pp. 224-250, U.S. Government Printing Office, Washington, DC, 1996.
17. KUCZENSKI, R. AND SEGAL, D. S.: Concomitant characterization of behavioral and striatal neurotransmitter response to amphetamine using in vivo microdialysis. J. Neurosci. 9: 2051-2065, 1989.
18. KUCZENSKI, R., SEGAL, D. S., CHO, A. K. AND MELEGA, W. P.: Hippocampus norepinephrine, caudate dopamine and serotonin, and behavioral responses to the stereoisomers of amphetamine and methamphetamine. J. Neurosci. 15: 1308-1317, 1995.
19. MACHIYAMA, Y.: Chronic methamphetamine intoxication model of schizophrenia in animals. Schizophrenia Bull. 18: 107-113, 1992.
20. MASON, G. J.: Stereotypies: A critical review. Anim. Behav. 41: 1015-1037, 1991.
21. MELEGA, W. P., WILLIAMS, A. E., SCHMITZ, D. A., DISTEFANO, E. W. AND CHO, A. K.: Pharmacokinetic and pharmacodynamic analysis of the actions of D-amphetamine and d-methamphetamine on the dopamine terminal. J. Pharmacol. Exp. Ther. 274: 90-96, 1995.
22. MITTLEMAN, G., JONES, G. H. AND ROBBINS, T. W.: Sensitization of amphetamine-stereotypy reduces plasma corticosterone: Implications for stereotypy as a coping response. Beh. Neur. Biol. 56: 170-182, 1991.
23. O'DELL, S. J., WEIHMULLER, F. B. AND MARSHALL, J. F.: Multiple methamphetamine injections induce marked increases in extracellular striatal dopamine which correlate with subsequent neurotoxicity. Brain Res. 564: 256-260, 1991.
24. PAULSON, P. E. AND ROBINSON, T. E.: Amphetamine-induced time-dependent sensitization of dopamine neurotransmission in the dorsal and ventral striatum: A microdialysis study in behaving rats. Synapse 19: 56-65, 1995.
25. REBEC, G. V. AND SEGAL, D. S.: Apparent tolerance to some aspects of amphetamine stereotypy with long-term treatment. Pharmacol. Biochem. Behav. 13: 793-979, 1980.
26. RYLANDER, G.: Clinical and medico-criminological aspects of addiction to central stimulating drugs. In Abuse of Central Stimulants, ed. by F. Sjoqvist and M. Tottie, Almqvist & W. Forlag AB, Stockholm, 1969.
27. RYLANDER, G.: Clinical and medico-criminological aspects of addiction to central stimulating drugs. In Use and Abuse of Amphetamine and Its Substitutes, ed. by J. V. Spotts and C. A. Spotts, pp. 299-300, U.S. Government Printing Office, Washington, D.C., 1980.
28. SATO, M., NUMACHI, Y. AND HAMAMURA, T.: Relapse of paranoid psychotic state in methamphetamine model of schizophrenia. Schizophrenia Bull. 18: 115-122, 1992.
29. SCHIORRING, E.: Changes in individual and social behavior induced by amphetamine and related compounds in monkeys and man. In Cocaine and Other Stimulants, ed. by E. H. Ellinwood and M. Kilbey, pp. 481-522, Raven Press, New York, 1977.
30. SCHMIDT, C. J., GEHLERT, D. R., PEAT, M. A., SONSALLA, P. K., HANSON, G. R., WAMSLEY, J. K. AND GIBB, J. W.: Studies on the mechanism of tolerance to methamphetamine. Brain Res. 343: 305-313, 1985a.
31. SCHMIDT, C. J., SONSALLA, P. K., HANSON, G. R., PEAT, M. A. AND GIBB, J. W.: Methamphetamine-induced depression of monoamine synthesis in the rat: development of tolerance. J. Neurochem. 44: 852-855, 1985b.
32. SEGAL, D. S.: Behavioral and neurochemical correlates of repeated damphetamine administration. In Advances in Biochemical Psychopharmacology, ed. by A. J. Mandell, pp. 247-266, Raven Press, New York, 1975.
33. SEGAL, D. S.: Differential effects of para-chlorophenylalanine on amphetamine-induced locomotion and stereotypy. Brain Res. 116: 267-276, 1976.
34. SEGAL, D. S.: Differential effects of serotonin depletion on amphetamine-induced locomotion and stereotypy. In Cocaine and Other Stimulants, ed. by E. H. Ellinwood and M. J. Kilbey, pp. 431-443, Raven Press, New York, 1977.
35. SEGAL, D. S. AND KUCZENSKI, R.: Individual differences in responsiveness to single and repeated amphetamine administration: behavioral characteristics and neurochemical correlates. J. Pharmacol. Exp. Ther. 242: 917-926, 1987.
36. SEGAL, D. S. AND KUCZENSKI, R.: An escalating dose 'binge' model of amphetamine psychosis: Behavioral and neurochemical characteristics. J. Neurosci. 17: 2551-2566, 1997.
37. SEGAL, D. S., KUCZENSKI, R. AND FLORIN, S. M.: Does dizocilpine (MK-801) selectively block the enhanced responsiveness to repeated amphetamine administration? Behav. Neurosci. 109: 532-546, 1995.
38. SEGAL, D. S., WEINBERGER, S., CAHILL, J. AND MCCUNNEY, S.: Multiple daily amphetamine administration: Behavioral and neurochemical alterations. Science 207: 904-907, 1980.
39. STAHLE, L., SEGERSVÄRD, S. AND UNGERSTEDT, U.: A comparison between three methods for estimation of extracellular concentrations of exogenous and endogenous compounds by microdialysis. J. Pharmacol. Methods 25: 41-52, 1991.
40. STEPHANS, S. E. AND YAMAMOTO, B.: Methamphetamine pretreatment and the vulnerability of the striatum to methamphetamine neurotoxicity. Neuroscience 72: 593-600, 1996.
41. WAGES, S. A., CHURCH, W. H. AND JUSTICE, J. B., JR.: Sampling considerations for on-line microbore liquid chromatography of brain dialysis. Analyt. Biochem. 58: 1649-1656, 1986.
42. WEIHMULLER, F. B., O'DELL, S. J. AND MARSHALL, J. F.: MK-801 protection against methamphetamine-induced striatal dopamine terminal injury is associated with attenuated dopamine overflow. Synapse 11: 155-163, 1992.